Merck Ltd. and the government-funded Development Center for Biotechnology (DCB) jointly announced yesterday a cooperation agreement to establish an Asia Technology Training Center (ATTC) in Taiwan.
Merck will invest approximately NT$10 million (US$308,000) in the training center, bringing its own systems and plans to have two to three lab technicians in addition to a technical manager, who will be responsible for coordinating clients throughout Asia, said William Chen (
"The initial investment is small, but the potential return on capital is exponential," he said.
Since DCB will be providing a majority of the talent and support, Merck will have a smaller staff, Chen said.
"The key is our technical manager, who will have to act as coordinator for clients across Asia and rely on our expertise in scale production of protein-based drugs and consulting services," Chen said.
"The ATTC is not merely a training center; it is where clients can come and use our expertise and perhaps inquire about technology transfer," he said.
German-based Merck established its Taiwan branch in 1989 and distributes laboratory equipment and raw ingredients for research in sciences. The company has two training centers in the world -- one in Germany and another in the US. ATTC will be the third facility and the only one in Asia.
Under the agreement, Merck will set up ATTC on the DCB campus in Sijhih City (汐止), Taipei County. DCB will provide the space, facilities, consultants and supplies, while Merck will share its cooperation model with customers and partner DCB in its global R&D efforts.
The competition to house this facility was high, with Japan, China, India and South Korea all vying for the opportunity to enhance their biotechnology sector, DCB officials said.
"DCB is quite pleased to have won Merck's approval. The joint proposal drawn up by Merck Taiwan and DCB was done within a week and beat out proposals from other Asian countries -- some of which had been working on the proposals for a year," said Huang Bor-fuei (
DCB and Merck Taiwan were able to edge out the competition as their proposal went beyond the simple concept of a "training center" and incorporated more business integration opportunities, Huang said.
Taiwan has an advantage in this sector in Asia because of its clear rules on intellectual property rights protection, DCB's well-established bioprocessing team and R&D facilities, and a current good manufacturing practice, or CGMP, pilot plant to support large-scale production, he said.
DCB chairman Wu Shuh-min (
Wu was referring to the legislature's approval of the Biotech and New Pharmaceutical Development Act (
"It also shows that Merck recognizes the efforts DCB has made in 2007 on the international stage, striking cooperation deals with Boehringer Ingelheim of Germany, Crucell of Netherlands and MediVas of the United States," Wu said
Looking ahead, DCB, and by corollary, Taiwan's biotechnology industry, will benefit from more international exposure and recognition, and smaller biotech firms will gain access to world-class consulting and services in protein-based drug production, Huang said.
One of several Taiwanese biotechnology firms present at yesterday's event said it had learned more about potential opportunities to cooperate with DCB.
“The case put forward by DCB looks good, and if costs are acceptable we will probably seek to cooperate with them. The services that Merck and DCB provide certainly helps the process of protein-based drug production,” said
Cheng Li-ting (鄭力廷), a researcher at Sijhih-based Yeastern Biotech Co Ltd (益生生技).
NO VIRUS BLUES: A SEMI Taiwan official said that the virus does not slow down the global semiconductor industry’s investment in manufacturing equipment The production value of the nation’s semiconductor industry is expected to grow 16.7 percent this year from last year, outpacing the global industry’s 3.3 percent growth, industry association SEMI said yesterday. That would help Taiwan safeguard its second spot in the global semiconductor market with a production value of more than NT$3 trillion (US$102.73 billion), SEMI Taiwan president Terry Tsao (曹世綸) told a media briefing in Taipei for the Semicon Taiwan trade show beginning today. The global semiconductor industry’s production value is expected to increase to US$426 billion this year, SEMI said. In terms of semiconductor equipment investment, equipment billings from Taiwanese firms
Intel Corp has received licenses from US authorities to continue supplying certain products to Huawei Technologies Co (華為), a company spokesman said yesterday. Washington has been pushing governments around to world to squeeze out Huawei, saying that the telecom giant would hand data to Beijing for espionage. From Monday last week, new curbs have barred US companies from supplying or servicing Huawei. This week, the state-backed China Securities Journal reported that Intel had received permission to supply Huawei. China’s Semiconductor Manufacturing International Corp (SMIC, 中芯國際), which uses US-origin equipment to make chips for Huawei and other companies, last week confirmed that it had sought
INVEST IN TAIWAN: A metal components casting firm and the world’s largest maker of aluminum bicycle rims also obtained approvals to join the program Solar Applied Materials Technology Co (SOLAR, 光洋應用材料), a part of Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) “green supply chain,” has pledged to invest NT$1 billion (US$34.1 million) to build a new plant at the Tainan Technology Industrial Park (台南科技工業區), the Ministry of Economic Affairs said yesterday. SOLAR has been collaborating with TSMC to extract precious metals from waste and reuse them as “sputtering target” material in high-end semiconductor manufacturing, a TSMC press release issued in May said. Established in 1978, SOLAR also offers key materials and integrated services to customers in the optoelectronics, information and communications technology, petrochemicals and consumer electronics industries,
‘SWARM TECH’: Joint venture FARobot is to develop autonomous mobile robots that would first be deployed in Hon Hai’s factories to optimize production efficiency Hon Hai Precision Industry Co (鴻海精密) and Adlink Technology Inc (凌華科技) have formed a robotic venture that aims to use “swarm technology” to create robots that can communicate with one another on the factory floor to optimize production efficiency. Hon Hai is Apple Inc’s leading iPhone assembler and the world’s largest contract electronics maker, while Adlink supplies industrial computers and Internet of Things solutions. Through a subsidiary, Hyield Venture Capital Co (鴻揚創投), Hon Hai holds a 51 percent stake in autonomous mobile robot (AMR) developer FARobot (法博智能移動), while Adlink owns the remaining 49 percent. Together, the two companies put up NT$200